For over a decade, Singapore has consistently ranked highly on the Global Innovation Index, an annual ranking of 130 economies. In 2024 it achieved its highest position yet – 4th globally. 

This strong performance is largely due to steady, long-term investment in research & development (R&D) as a key pillar of Singapore’s economic development strategy.

Supporting Singapore’s Research, Innovation and Enterprise (RIE) ecosystem is the Singapore Advanced Research and Education Network (SingAREN), established in 1997. SingAREN is the sole provider of dedicated local and international network services for the local Research and Education community.

SingAREN’s network supports the SingAREN Open Exchange (SOE) for high-speed research and education connectivity, eduroam, an international Wi-Fi internet access roaming service for the international research and education community, and FileSender SG as a platform for large file transfers, among other services running on its network.

RIE is vital to Singapore’s progress, fostering economic growth and competitiveness. It also drives scientific advancements that can potentially address societal challenges and enhance our well-being.

SingAREN has supported robotic telesurgery trials across international boundaries, which require precise, instantaneous control, and a low-latency network for real-time collaboration.

SingAREN also enables high-speed, resilient connectivity to the National Supercomputing Center (NSCC), which manages Singapore’s national high-performance computing (HPC) resources, supporting research and innovation across various fields. In particular, the NSCC’s expertise and specialized infrastructure are often leveraged to manage and analyze genomic data. Transferring genomic data is typically difficult due to its massive data size.

SingAREN provided a high-speed link to the Cancer Science Institute of Singapore for a research project, transmitting more than 2 petabytes of cancer genomics data downloaded from repositories in the United States into NSCC. The research involved harmonizing petabytes of whole genome sequencing data, and downloads were expected to be extremely fast, stable, and efficient, after which, the downloaded data would be analyzed and reprocessed with high computing power.

This is but one of the examples of collaboration with NSCC to transfer, download, analyze and process genomic data.

Academic research is experiencing explosive growth and requires more data than ever before, fuelled by AI and Machine Learning (ML), and cloud computing. The increasing use of generative and agentic AI will also impact SingAREN and its research partners significantly, leading to increased data volume. This type of advanced research activity will not be possible without a robust, scalable, low-latency network.

In the coming months, SingAREN will enhance its network to further support its research institution partners. These plans include the SingAREN Lightwave Internet Exchange (SLIX) 2.5 project, to provide high-speed, secure connectivity by 2027, and the SLIX 3.0 vision to build a future-ready network that incorporates quantum-safe networking, AI research, and haptic surgery. SingAREN also aims to expand cybersecurity threat intelligence sharing and continue infrastructure upgrades, such as implementing 400G switches and enhancing Points of Presence (PoP) resilience.

SingAREN uses Ciena’s 6500 powered by Ciena’s WaveLogic programmable coherent optic technology. Deployed by Ciena partner, Terrabit Networks, Ciena’s 6500 supports SingAREN to respond to changing requirements on-demand, allowing the REN to continually maximize network efficiencies and offer customizable service delivery over any distance.

SoundHound AI (SOUN -4.73%) stock saw a pullback in Thursday’s trading. The company’s share price fell 4.7% in the session and had been down as much as 8.1% earlier in trading.

While there doesn’t appear to have been any major business-specific news behind the pullback, investors may have moved to take profits after a pop for the company’s share price earlier in the week. Despite today’s pullback, the stock is still up roughly 9% over the last week of trading. Even more striking, the company’s share price is up roughly 39% over the last three months.

Is SoundHound AI stock a good buy right now?

SoundHound AI has been highly volatile over the last year of trading. While the company’s share price is still up roughly 197% across the stretch, it’s also still down approximatley 49% from its peak in the period.

Even as the company’s sales base has ramped up rapidly, sales growth has continued to accelerate. Revenue increased 151% year over year in the first quarter of the company’s current fiscal year, which ended March 31. The company still only posted $29.1 million in sales in the period, but sales growth in the quarter marked a dramatic improvement over the 73% annual growth it posted in the prior-year period.

SoundHound is an early mover in the voice-based agentic artificial intelligence (AI) space, and it has huge expansion potential over the long term — but its valuation profile still comes with a risk. The company now has a market capitalization of roughly $4.9 billion and is valued at approximately 31 times this year’s expected sales.

For investors with a very high risk tolerance, SoundHound AI could still be a worthwhile investment. The company has been posting very impressive sales momentum, but its valuation already prices in a lot of strong growth in the future. If you’re looking to build a position in SoundHound AI stock, using a dollar-cost-averaging strategy for your purchases may be better than buying in all at once at today’s prices.

Browse 902 market data Tables and 67 Figures spread through 711 Pages and in-depth TOC on “Artificial Intelligence (AI) in Healthcare Market by Offering (Integrated), Function (Diagnosis, Genomic, Precision Medicine, Radiation, Immunotherapy, Pharmacy, Supply Chain), Application (Clinical), End User (Hospitals), Region – Global Forecast to 2030
The global Artificial Intelligence (AI) in Healthcare Market [https://www.marketsandmarkets.com/Market-Reports/artificial-intelligence-healthcare-market-54679303.html?utm_source=abnewswire.com&utm_medium=paidpr&utm_campaign=artificialintelligenceinhealthcaremarket], valued at US$14.92 billion in 2024, is forecasted to grow at a robust CAGR of 38.6%, reaching US$21.66 billion in 2025 and an impressive US$110.61billion by 2030. The growing incidence of chronic diseases, linked with an increasing geriatric population, puts substantial financial pressure on healthcare providers. There is a rising need for the early detection of conditions such as dementia and cardiovascular disorders. This can be done by analysing imaging data to recognize patterns, which helps create personalized treatment plans.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=54679303 [https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=54679303&utm_source=abnewswire.com&utm_medium=paidpr&utm_campaign=artificialintelligenceinhealthcaremarket]

Browse in-depth TOC on “Artificial Intelligence (AI) in Healthcare Market”

882 – Tables

61 – Figures

738 – Pages

By tools, the Artificial Intelligence (AI) in healthcare market for machine learning has been bifurcated into deep learning, supervised learning, reinforcement learning, unsupervised learning, and other machine learning technologies. The deep learning segment accounted for the largest share of the Artificial Intelligence (AI) in healthcare market in 2024. The capability to process vast amounts of unstructured medical data, such as electronic health records (HER), imaging, and genomics, allows accurate disease diagnosis and prediction. The integration of deep learning into healthcare is significantly boosting the AI in healthcare market, leading to substantial investments in diagnostic tools and predictive analytics. As computational power and data availability continue to increase, deep learning is set to unlock further advancements, solidifying its position as a key enabler of next-generation healthcare technologies.

By end user, the AI in healthcare market is segmented into healthcare providers, healthcare payers, patients, and other end users. In 2024, healthcare providers accounted for the largest share of the AI in healthcare market. The large share of this end-user segment can be attributed to the increasing budgets of hospitals to improve the quality of care provided and reduce the cost of care.

By geography, the Artificial Intelligence (AI) in healthcare market is segmented into five main regions: North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. The Asia Pacific region is projected to see a substantial growth rate during the forecast period. The Asia Pacific (APAC) region is experiencing substantial growth in adopting AI technologies within the healthcare sector, driven by a combination of demographic shifts, technological advancements, and increased investments in innovation. The rising elderly population in the region is a key factor, with the proportion of individuals aged 65 years and above increasing significantly. The demand for advanced healthcare solutions has surged as the aging population faces chronic and age-related conditions, necessitating efficient diagnostic, monitoring, and treatment tools. AI technologies are being integrated into various healthcare applications, including predictive analytics, telemedicine, medical imaging, and patient management systems. These innovations aim to address gaps in healthcare access, improve diagnostic accuracy, and streamline operations across the region.

Request Sample Pages : https://www.marketsandmarkets.com/requestsampleNew.asp?id=54679303 [https://www.marketsandmarkets.com/requestsampleNew.asp?id=54679303&utm_source=abnewswire.com&utm_medium=paidpr&utm_campaign=artificialintelligenceinhealthcaremarket]

The prominent players operating in the Artificial Intelligence (AI) in healthcare market include Koninklijke Philips N.V. (Netherlands), Microsoft Corporation (US), Siemens Healthineers AG (Germany), NVIDIA Corporation (US), Epic Systems Corporation (US), GE Healthcare (US), Medtronic (US), Oracle (US), Veradigm LLC (US), Merative (IBM) (US), Google (US), Cognizant (US), Johnson & Johnson (US), Amazon Web Services, Inc. (US), among others. These companies adopted strategies such as product launches, product updates, expansions, partnerships, collaborations, mergers, and acquisitions to strengthen their market presence in the Artificial Intelligence (AI) in healthcare market.

Koninklijke Philips N.V. (Netherlands)

Koninklijke Philips N.V. is a leading player in the AI in the healthcare market. The company utilizes AI to deliver innovative tools across various areas, including diagnostic imaging, patient monitoring, and precision medicine. Its advanced AI-driven platforms, such as the Philips HealthSuite, facilitate the integration and analysis of extensive clinical data, which supports personalized treatment plans and improves patient outcomes. Philips focuses on organic and inorganic growth strategies to expand its market presence.

Strategic partnerships in high-potential markets and collaborations have been the key growth strategies of the company over the years. For example, in February 2025, Philips partnered with Medtronic to educate and train cardiologists and radiologists in India on advanced imaging techniques for structural heart diseases. This partnership aims to upskill 300+ clinicians in multi-modality imaging such as echocardiography (echo) and Magnetic Resonance Imaging (MRI), especially for End-Stage Renal Disease (ESRD) patients. In November 2023, Philips and NYU Langone Health partnered to focus on patient safety and outcomes. This partnership integrated innovative health technologies, including digital pathology, clinical informatics, and AI-enabled diagnostics, enabling real-time collaboration among clinicians. The company also focuses on winning contracts across several companies in the healthcare space. This helps the company expand its footprint. For instance, in September 2022, Philips and Mandaya Royal Hospital Puri (MRHP) in Jakarta underwent a digital transformation in a strategic partnership, enhancing patient-centered care and healthcare services.

Microsoft Corporation (US):

Microsoft Corporation is one of the leading providers of software & tools that include advanced AI capabilities in healthcare to improve patient outcomes, streamline operations, and drive innovation. Its Azure-based AI solutions support distinct applications such as medical imaging, genomics, and precision medicine. The company also provides healthcare-specific AI models through its Azure AI Model Catalog, which is constructed to support hospitals and research institutions in building and deploying tailored AI solutions proficiently. Moreover, the integration of Nuance’s AI-powered clinical and diagnostic tools encourages its capacity to support healthcare providers in decision-making and care delivery. The company continuously brings AI capabilities to the platforms in large-scale customer models. For instance, in March 2025, the company launched Microsoft Dragon Copilot, the first unified voice AI assistant in the healthcare industry that enables clinicians to streamline clinical documentation, surface information, and automate tasks.

Microsoft Corporation has invested significantly in R&D, which has improved its product portfolio and position in the AI market. Machine Learning (ML), deep learning, Natural Language Processing (NLP), and speech processing are the key focus areas of the company in the AI in healthcare market. The company continuously invests in a series of services and computational biology projects, including research support tools for next-generation precision healthcare, genomics, immunomics, CRISPR, and cellular and molecular biologics. It has a strong global presence, with key operations supported through its Azure cloud infrastructure across regions like North America, Europe, Asia-Pacific, and the Middle East.

For more information, Inquire Now! [https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=54679303&utm_source=abnewswire.com&utm_medium=paidpr&utm_campaign=artificialintelligenceinhealthcaremarket]

Media Contact
Company Name: MarketsandMarkets Trademark Research Private Ltd.
Contact Person: Mr. Rohan Salgarkar
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=artificial-intelligence-ai-in-healthcare-market-worth-11061-billion-by-2030]
Phone: 18886006441
Address:1615 South Congress Ave. Suite 103, Delray Beach, FL 33445
City: Florida
State: Florida
Country: United States
Website: https://www.marketsandmarkets.com/Market-Reports/artificial-intelligence-healthcare-market-54679303.html

Legal Disclaimer: Information contained on this page is provided by an independent third-party content provider. ABNewswire makes no warranties or responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you are affiliated with this article or have any complaints or copyright issues related to this article and would like it to be removed, please contact retract@swscontact.com

This release was published on openPR.